Magpie Pharmaceuticals
Guangzhou
About Magpie Pharmaceuticals
Magpie Pharmaceuticals specialize in the research and development of first-in-class drugs. The company focuses on the structural modification and transformation of active natural product monomers in traditional Chinese medicines (TCM), as well as small molecular compounds currently in clinical use.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $28.8M
- Funding stage: Late Stage Venture
- Last round: Series C (Apr 2020)
- Website: magpiepharma.com
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Canonical: https://fsome.com/organization/magpie-pharmaceuticals-65960 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.